Northwest Biotherapeutics (NWBO) Gross Profit (2010 - 2013)

Northwest Biotherapeutics' Gross Profit history runs 4 years deep, the most recent figure standing at $400000.0 for Q3 2013.

• On a quarterly basis, Gross Profit changed N/A year-over-year to $400000.0 in Q3 2013; TTM through Mar 2014 was $672000.0, a 314.7% increase from a year earlier, with the FY2013 full-year figure at $809000.0, changed N/A from the prior year.
• Gross Profit grew to $400000.0 in Q3 2013 per NWBO's latest filing, from $272000.0 in the prior quarter.
• Across five years, Gross Profit topped out at $400000.0 in Q3 2013 and bottomed at -$450000.0 in Q4 2012.
• The 4-year median for Gross Profit is $73500.0 (2010), against an average of $63166.7.
• Biggest YoY gain for Gross Profit was 0.0% in 2011; the steepest drop was 0.0% in 2011.
• Year by year, Gross Profit stood at $10000.0 in 2010, then changed by 0.0% to $10000.0 in 2011, then slumped by 4600.0% to -$450000.0 in 2012, then soared by 188.89% to $400000.0 in 2013.
• Per Business Quant, the three latest NWBO Gross Profit figures stand at $400000.0 (Q3 2013), $272000.0 (Q2 2013), and $137000.0 (Q1 2013).